Caxton Corp Addex Therapeutics Ltd. Transaction History

Caxton Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.05 - $5.35 $279,237 - $1.42 Million	-265,940 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$9.79 - $24.19 $2.43 Million - $6.01 Million	248,542 Added 1428.57%	265,940 $3.56 Million
Q3 2020 Nov 16, 2020	SELL	$7.0 - $21.0 $140 - $420	-20 Reduced 0.11%	17,398 $213,000
Q1 2020 May 15, 2020	BUY	$6.19 - $14.5 $107,817 - $252,561	17,418 New	17,418 $115,000

Ticker ADXN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,204,630
Market Cap $65.6M
Description
Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs includ...

Get notified when there are updates to the investment portfolio of Caxton Corp, based on Form 13F filings with the SEC.

Stay updated on Caxton Corp with notifications on news.